Search for: "Mayo" Results 4381 - 4400 of 6,459
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Apr 2012, 10:00 pm by Stephanie Figueroa
Supreme Court on March 20, 2012 issued its decision in Mayo Collaborative Services v. [read post]
1 Apr 2012, 9:55 pm by Patent Docs
April 3, 2012 - Contested Proceedings Before the New Patent Trial and Appeal Board: Navigating PTO Practice Under the New Procedures (Strafford) - 1:00 - 2:30 pm (EDT) April 5, 2012 - Personalized Medicine after Prometheus: Exploring the Limits of Patent-Eligibility (Intellectual Property Owners Association) - 2:00 pm (ET) April 9, 2012 - Mayo v. [read post]
1 Apr 2012, 1:20 pm by David Harlow
 To those who have not: the HealthBlawger hopes that this post will alert those who have not to avail themselves of the plethora of resources available to them: other health care social media privacy and security content here on HealthBlawg, the Mayo Clinic Center for Social Media (disclosure: I sit on its external advisory board), among many others -- please share any favorites in the comments. [read post]
30 Mar 2012, 6:15 pm by Patent Docs
Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff; Jonathan Singer of Fish & Richardson, who has represented the Mayo Clinic in its patent litigation with Prometheus; and Bryan Zielinski, Vice President, Assistant General Counsel, and Head of Pfizer's Business Unit IP group, will examine ways forward after the Mayo decision. [read post]
30 Mar 2012, 6:10 pm by Patent Docs
Law Seminars International (LSI) will be offering a one-hour analysis on "Mayo v. [read post]
30 Mar 2012, 11:24 am by Antoinette Konski
The other day I had the opportunity to speak with Colin O’Keefe of LXBN TV on the subject of Mayo Collaborative Services v. [read post]
30 Mar 2012, 9:18 am by Rosalba Pinedo
Permitir que los contribuyentes que no se encuentren obligados a dictaminar sus estados financieros de conformidad con el artículo 32-A del CFF así como los contribuyentes que en el ejercicio inmediato anterior hayan obtenido ingresos acumulables hasta por $40,000,000.00, calculen y determinen los pagos provisionales mensuales del impuesto empresarial a tasa única a través de un procedimiento combinado, calculen el pago provisional de los meses impares del ejercicio… [read post]
30 Mar 2012, 8:30 am by Eric Guttag
” But frankly such mishandling of binding Supreme Court precedent in Mayo Collaborative Services is a huge problem. [read post]
30 Mar 2012, 7:11 am
Here's a list of symptoms, according the Mayo Clinic website (boldface added): Signs and symptoms of a broken nose may appear immediately or may take up to three days to develop. [read post]
30 Mar 2012, 3:14 am by Mi Patente
La empresa fue fundada el  28 de mayo de 1937 por la Asociación Automovilística Alemana en Wolfsburg Alemania, por la necesidad que tenia la población de contar con un sistema de transporte privado accesible para un mayor número de ciudadanos, recibió un importante apoyo por parte del gobierno de Adolf Hitler, pues considero clave para sus aspiraciones, motorizar a su pueblo. [read post]
29 Mar 2012, 10:00 pm by Stephanie Figueroa
Myriad Genetics and ordering the appellate court to reconsider the case in light of the recent Supreme Court decision in Mayo v. [read post]
29 Mar 2012, 10:00 pm by Stephanie Figueroa
Myriad Genetics and ordering the appellate court to reconsider the case in light of the recent Supreme Court decision in Mayo v. [read post]
29 Mar 2012, 4:35 pm by Colin O'Keefe
We also have some SCOTUS talk on LXBN TV as Antoinette Konski joins us to talk Mayo v. [read post]
29 Mar 2012, 3:12 pm
Signs of P.T.S.D. can, according to the Mayo Clinic, take years to develop. [read post]
29 Mar 2012, 1:36 pm
Patent lawyers for Prometheus Laboratories, Inc. of San Diego, California filed a patent infringement suit against Mayo Collaborative Services, doing business as Mayo Medical Laboratories of Rochester, Minnesota, alleging that Mayo infringed patent no. 6,355,623, Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage and patent no. 6,680,302, Methods of optimizing drug therapeutic… [read post]